首页|抑制3型脱碘酶表达能通过上调过氧化物酶体增殖物激活受体γ共激活因子1α改善脓毒症骨骼肌线粒体功能

抑制3型脱碘酶表达能通过上调过氧化物酶体增殖物激活受体γ共激活因子1α改善脓毒症骨骼肌线粒体功能

扫码查看
目的 探讨靶向抑制3型脱碘酶(Dio3)对脓毒症骨骼肌线粒体的保护作用及其机制.方法 ①体内实验:通过盲肠结扎穿孔术(CLP)构建脓毒症大鼠模型;利用腺相关病毒靶向干扰大鼠胫骨前肌Dio3的表达.按随机数字表法将雄性SD大鼠分为阴性敲除假手术组(shNC+Sham组)、阳性敲除假手术组(shD3+Sham组)、阴性敲除CLP组(shNC+CLP组)和阳性敲除CLP组(shD3+CLP组),每组8只.制模后取胫骨前肌,用蛋白质免疫印迹试验(Western blotting)检测Dio3、过氧化物酶体增殖物激活受体γ共激活因子1α(PGC1α)、沉默信息调节因子1(SIRT1)等蛋白表达;实时荧光定量聚合酶链反应(RT-qPCR)检测甲状腺激素受体(THRα、THRβ)、单羧酸转运蛋白10(MCT10)等T3调控基因,线粒体DNA(mtDNA),线粒体生物合成相关基因PGC1α的mRNA表达;透射电镜下观察线粒体形态.②体外实验:体外培养小鼠成肌样细胞C2C12,利用慢病毒干扰Dio3表达,并用脂多糖(LPS)构建内毒素细胞模型,并分为shNC组、shD3组、shNC+LPS组和shD3+LPS组.免疫荧光染色分析PGC1α胞内分布.免疫共沉淀联合Western blotting检测PGC1α乙酰化水平.结果 ①体内实验:与shNC+Sham组相比,shNC+CLP组骨骼肌内Dio3蛋白表达明显升高(Dio3/β-Tubulin:3.32±0.70 比 1.00±0.49,P<0.05),而 shD3+Sham 组无差异;shD3+CLP 组 Dio3 蛋白表达较 shNC+CLP 组明显降低(Dio3/β-Tubulin:1.42±0.54 比 3.32±0.70,P<0.05).与 shNC+CLP 组相比,shD3+CLP 组 T3 调控基因的表达明显上调[THRα mRNA(2-△△Ct):0.67±0.05 比 0.33±0.01,THRβ mRNA(2-△△Ct):0.94±0.05 比0.67±0.02,MCT10 mRNA(2-△△Ct):0.65±0.03 比 0.57±0.02,均 P<0.05].电镜结果提示,shNC+CLP组骨骼肌线粒体损伤明显,而shD3+CLP组线粒体形态保持完整;与shNC+Sham组相比,shNC+CLP组线粒体数量明显减少(个/HP:10.375±1.375 比 13.750±2.063,P<0.05),而 shD3+CLP 组线粒体数量较 shNC+CLP 组明显增多(个/HP:11.250±2.063 比 10.375±1.375,P<0.05);shNC+CLP 组 mtDNA 表达较 shNC+Sham 组明显降低(拷贝数:0.842±0.035 比 1.002±0.064,P<0.05),而 shD3+CLP 组 mtDNA 表达与 shNC+CLP 组无差异,但明显高于 shD3+Sham 组(拷贝数:0.758±0.035 比 0.474±0.050,P<0.05).与 shNC+CLP 组相比,shD3+CLP 组PGC1α的转录及蛋白水平均明显改善[PGC1α mRNA(2-△△Ct):1.49±0.13比0.68±0.06,PGC1α蛋白相对表达量(PGC1α/β-Tubulin):0.76±0.02 比 0.62±0.04,均 P<0.05].②体外实验:LPS 干预 24 h 后,shNC+LPS组PGC1α胞内定位弥散;干扰Dio3表达后促使PGC1α向核周及核内移位.与shNC+LPS组比较,shD3+LPS组PGC1α的乙酰化水平明显降低(乙酰化PGC1α/β-Tubulin:0.59±0.01比1.24±0.01,P<0.05),而介导蛋白去乙酰化的主要蛋白SIRT1的表达明显升高(SIRT1/β-Tubulin:1.04±0.04比0.58±0.03,P<0.05).利用EX527抑制SIRT1 活性后,shD3+LPS+EX527组PGC1α 蛋白表达较shD3+LPS组明显降低(PGC1α/β-Tubulin:0.92±0.03比1.58±0.03,P<0.05).结论 抑制骨骼肌Dio3表达可以通过激活SIRT1减轻PGC1α的乙酰化修饰,促使PGC1α向核内移位,从而对脓毒症导致的骨骼肌线粒体损伤起到保护作用.
Inhibition of type 3 deiodinase expression can improve mitochondrial function in skeletal muscle of sepsis by up-regulating peroxisome proliferator-activated receptor-γ coactivator-1α
Objective To investigate the protective effects and mechanisms of targeted inhibition of type 3 deiodinase(Dio3)on skeletal muscle mitochondria in sepsis.Methods ① In vivo experiments:adeno-associated virus(AAV)was employed to specifically target Dio3 expression in the anterior tibial muscle of rats,and a septic rat model was generated using cecal ligation and puncture(CLP).The male Sprague-Dawley(SD)rats were divided into shNC+Sham group,shD3+Sham group,shNC+CLP group,and shD3+CLP group by random number table method,with 8 rats in each group.After CLP modeling,tibial samples were collected and Western blotting analysis was conducted to assess the protein levels of Dio3,peroxisome proliferator-activated receptor-γ coactivator-1α(PGC1α),and silence-regulatory protein 1(SIRT1).Real-time fluorescence quantitative polymerase chain reaction(RT-qPCR)was utilized to examine mRNA expression of genes including thyroid hormone receptors(THR α,THR β),monocarboxylate transporter 10(MCT10),mitochondrial DNA(mtDNA),and PGC1α.Transmission electron microscopy was employed to investigate mitochondrial morphology.② In vitro experiments:involved culturing C2C12 myoblasts,interfering with Dio3 expression using lentivirus,and constructing an endotoxin cell model by treating cells with lipopolysaccharide(LPS).C2C12 cells were divided into shNC group,shD3 group,shNC+LPS group,and shD3+LPS group.Immunofluorescence colocalization analysis was performed to determine the intracellular distribution of PGC1α.Co-immunoprecipitation assay coupled with Western blotting was carried out to evaluate the acetylation level of PGC1α.Results ① In vivo experiments:compared with the shNC+Sham group,the expression of Dio3 protein in skeletal muscle of the shNC+CLP group was significantly increased(Dio3/β-Tubulin:3.32±0.70 vs.1.00±0.49,P<0.05),however,there was no significant difference in the shD3+Sham group.Dio3 expression in the shD3+CLP group was markedly reduced relative to the shNC+CLP group(Dio3/β-Tubulin:1.42±0.54 vs.3.32±0.70,P<0.05).Compared with the shNC+CLP group,the expression of T3-regulated genes in the shD3+CLP group were restored[THR α mRNA(2-△△Ct):0.67±0.05 vs.0.33±0.01,THR βmRNA(2-△△Ct):0.94±0.05 vs.0.67±0.02,MCT10 mRNA(2-△△Ct):0.65±0.03 vs.0.57±0.02,all P<0.05].Morphology analysis by electron microscopy suggested prominent mitochondrial damage in the skeletal muscle of the shNC+CLP group,while the shD3+CLP group exhibited a marked improvement.Compared with the shNC+Sham group,the shNC+CLP group significantly reduced the number of mitochondria(cells/HP:10.375±1.375 vs.13.750±2.063,P<0.05),while the shD3+CLP group significantly increased the number of mitochondria compared to the shNC+CLP group(cells/HP:11.250±2.063 vs.10.375±1.375,P<0.05).The expression of mtDNA in shNC+CLP group was markedly reduced compared with shNC+Sham group(copies:0.842±0.035 vs.1.002±0.064,P<0.05).Although no difference was detected in the mtDNA expression between shD3+CLP group and shNC+CLP group,but significant increase was found when compared with the shD3+Sham group(copies:0.758±0.035 vs.0.474±0.050,P<0.05).In the shD3+CLP group,PGC1α expression was significantly improved at both transcriptional and protein levels relative to the shNC+CLP group[PGC1α mRNA(2-△△Ct):1.49±0.13 vs.0.68±0.06,PGC1α/β-Tubulin:0.76±0.02 vs.0.62±0.04,both P<0.05].② In vitro experiments:post-24-hour LPS treatment of C2C12 cells,the cellular localization of PGC1α became diffuse;interference with Dio3 expression promoted PGC1α translocation to the perinuclear region and nucleus.Moreover,the acetylated PGC1α level in the shD3+LPS group was significantly lower than that in the shNC+LPS group(acetylated PGC1α/β-Tubulin:0.59±0.01 vs.1.24±0.01,P<0.05),while the expression of the deacetylating agent SIRT1 was substantially elevated following Dio3 inhibition(SIRT1/β-Tubulin:1.04±0.04 vs.0.58±0.03,P<0.05).When SIRT1 activity was inhibited by using EX527,PGC1α protein expression was notably decreased compared to the shD3+LPS group(PGC1α/β-Tubulin:0.92±0.03 vs.1.58±0.03,P<0.05).Conclusion Inhibition of Dio3 in skeletal muscle reduced the acetylation of PGC1α through activating SIRT1,facilitating nuclear translocation of PGC1α,thereby offering protection against sepsis-induced skeletal muscle mitochondrial damage.

SepsisType 3 deiodinaseMitochondrial injuryPeroxisome proliferator-activated receptor-γ coactivator-1αMetabolic resuscitation

王刚、段剑锋、曹科、高涛、蒋安琪、许芸、朱章华、虞文魁

展开 >

南京大学医学院附属鼓楼医院重症医学科,江苏南京 210008

医药生物技术国家重点实验室,江苏南京 210008

脓毒症 3型脱碘酶 线粒体损伤 过氧化物酶体增殖物激活受体γ共激活因子1α 代谢复苏

国家自然科学基金国家自然科学基金

8200208282302442

2024

中华危重病急救医学
中华医学会

中华危重病急救医学

CSTPCD北大核心
影响因子:3.049
ISSN:2095-4352
年,卷(期):2024.36(8)